Clinical Feasibility & Validation of the Augmented Reality GlenxRose Acquired Brain Injury Rehabilitation Programs

Launched by UNIVERSITY OF ALBERTA · Jun 8, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new rehabilitation program using augmented reality (AR) to help patients recover from acquired brain injuries, strokes, or traumatic brain injuries. The goal is to make therapy more engaging and enjoyable, which can help patients stick to their rehabilitation plans. By using AR, the program aims to turn traditional therapy sessions into fun, game-like experiences, potentially improving patients' motivation and overall recovery outcomes compared to standard methods.

To participate in this trial, you need to be an adult receiving treatment at the Glenrose Rehabilitation Hospital in Edmonton, Canada, for mild to moderate acquired brain injury and be able to use an AR headset. Unfortunately, individuals with severe brain injuries or certain cognitive and communication challenges won't be eligible. If you join, you can expect to use the AR technology during your therapy sessions, and your feedback will help shape how this innovative approach can be integrated into regular care. This trial is currently recruiting participants, and it aims to enhance the rehabilitation experience while also looking at costs and overall satisfaction with treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults receiving care at the Glenrose Rehabilitation Hospital (Edmonton, Canada) for mild to moderate Acquired Brain Injury
• • Proficiency in English
• • Adequate upper-limb strength and coordination to utilize AR headset (determined by clinicians)
• Exclusion Criteria:
• • Pediatric populations
• • Severe acquired brain injury
• • severe cognitive and behavioural disorders (e.g. agitation, confusion, aggressive behaviour), which is Level V or higher on the Rancho Los Amigos Levels of Cognitive Functioning Scale
• • Severe aphasia, impacting language comprehension
• • Communication disorders that impact comprehension of verbal commands and understanding of scale used in the study
• • Previous neurological and/or psychiatric disorders
• • Substance misuse disorders
• • Previously acquired brain injury
• • Impairments that limit the interaction with the AR device